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Immunity has  been  demonstrated  to  be  a  significant  determinant  in  the 
pathogenesis  of  experimental  hematogenous  pyelonephritis  in  rats  infected 
with  strains  of Escherichia  coli,  Klebsidla  pneumoniae,  or  Proteus  mirabilis 
(1). Specifically, either active or passive preimmunizafion resulted in decreased 
infection  following  subsequent  hematogenous  challenge  by  the  homotypic 
strain.  However,  preimmunization  could  confer resistance  to  hematogenous 
pyelonephritis  by  promoting  the  more  rapid  removal  of  bacteria  from  the 
circulation,  thereby diminishing the inoculum to which  the  kidney  was  ex- 
posed, rather than by retarding the localization and multiplication of bacteria 
within the kidney. If resistance to hematogenous pyelonephritis were the con- 
sequence of accelerated vascular clearance, the phenomenon would be of less 
biological  significance,  as  there  is  considerable  evidence that  the  ascending 
route of infection is of major importance in the pathogenesis of pyelonephritis 
(2, 3). 
The studies which form the basis of this report demonstrate that preimmuni- 
zafion  resulted  in  the  development  of  acquired  resistance  in  experimental 
retrograde pyelonephritis following intravesical challenge by Proteus mirabilis. 
Hence, accelerated intravascular clearance of a  bacterial inoculum could not 
be  the  sole  mechanism  whereby  immunization  afforded  protection  against 
reinfection. Furthermore,  late  recrudescence of infection initially suppressed 
by means of preimmunization was not observed. 
Methods 
Experimental retrograde pyelonephritis  was produced in male rats of the Sprague-Dawley 
strain obtained from Holtzman Farms (Madison, Wisconsin), weighing 200 to 300 gin main- 
* Presented in part before the 34th meeting of the Central Society for Clinical Research, 
Chicago, November 3, 1961. 
:~ These studies were performed under Public Health Service Research Grant  AL02064 
from the National Institute of Allergy and Infectious Disease and United States Army Re- 
search and Development Command Contract DA49-007-MD-884. 
§ Studies performed during appointment as Research Fallow under Public Health Service 
Grants EF-5948 and TI-AI-30 of the National Institute of Allergy and Infectious Disease. 
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tained on "basic standard diet" obtained from Uncle Johnny Mills (Houston) and water ad 
libitum.  Infection was produced by the intravesical injection of the strain of Proteus mirabilis 
employed in earlier hematogenous studies (1). This strain was originally isolated from a pa- 
tient with the clinical diagnosis of pyelonephritis. The bladder was exposed through a supra- 
pubic incision, any urine present was aspirated, then 0.2 ml of a  1:50 dilution of an 18 hour 
trypticase  soy broth  (Baltimore Biological Laboratories,  Baltimore)  culture was  injected, 
and the suprapubic incision was sutured. The inoculum ranged from 10  s to  10  l° viable bac- 
teria. 
Evaluation of Renal Infections.--Experimental animals were sacrificed at varying intervals 
and through a suprapubic incision urine was obtained for culture. The kidneys were removed 
aseptically and the extent of abscesses, presence of hydronephrosis, hydro-ureter, urinary tract 
calculi, and infection of seminal vesicles were semiquantitated on the basis of 0 to 4+. The 
individual kidneys were weighed, then ground with trypticase soy broth and sand using a 
mortar and pestle, Tenfold serial dilutions of urine and the tissue suspension were made and 
pour plates made utilizing MacConkey agar (Baltimore Biological Laboratories). Numbers of 
bacteria were expressed per gram wet weight of renal tissue. 
Determinative bacteriology was performed on representative colonies from each urine or 
kidney specimen. Identification of reisolates as the original strain of Proteus  mirabilis  was 
made by agglutination of at least 3 representative colonies with specific hyperimmune rabbit 
antiserum. 
Blood urea nitrogen determinations were performed by the urease method of Karr (4) on 
blood specimens using sodium versenate as an anticoagulant. The mean normal value was 
26.4 mg per cent -4- 9.5 mg per cent. 
Serologic Techniques.--Proteus  m#abilis antigen was prepared by inoculating flasks con- 
taining 250 ml of trypticase soy broth with a stock culture of P. mirabilis,  then incubating 18 
hours at 37°C. The cultures were boiled for 2 hours, centrifuged, and the supernatant discarded. 
The sediment was resuspended in an equal volume of saline solution (250 ml), formalinized 
(0.5  per cent), and stored at 4°C prior to use. 
Antibody levels were determined by the following agglutination procedure: Twofold serial 
dilutions using 4-drop quantities of saline and an initial 1: 5 dilution of rat serum were made. 
An equal volume (4 drops) of antigen solution was added. Final dilutions ranged from 1:10 
to 1 : 10240. Tubes were incubated at 37°C for 3 hours, refrigerated for 48 hours at 4°C, and 
macroscopic agglutination noted. 
Immunization Procedures.-- 
Immunization by previous renal infection: Acute pyelonephritis was produced by the hema- 
togenous injection of P. mirabilis  followed by light renal massage according to a  technique 
previously described in detail (1). One week later the infection was eradicated by a  2 week 
course of antibiotic therapy consisting of chloramphenico150 mg per kg twice daily, and kana- 
mycin 50 mg per kg twice daily (5). The animals were then allowed a  7 day period for any 
residual antibiotics to be excreted or  degraded.  This therapeutic regimen was effective in 
eradication of  the antecedent infection. 
Immunization by killed bacteria: P. mirabilis  antigen was prepared by boiling an 18 hour 
trypticase soy broth culture for 2 hours, followed by centrifugation, and resuspension in 0.9 
per cent saline solution to ~0 of the original volume. 1.0 ml of this antigen was injected sub- 
cutaneously on days 1 and 5; on day 7, 0.25 ml of the antigen was injected intravenously. 
Passive immunization:  Rabbits weighing 3 kg received increasing quantities (0.5 to 10 mg 
per injection) of killed organisms daily by intravenous injection over a  3 week period. The 
animals were bled and antisera preserved with 1 ml of 1:5000 merthiolate per 10 ml of serum 
and stored at -- 4°C. The rabbit antisera were administered intravenously prior to retrograde 
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RESULTS 
Course  of  Retrograde Proteus  mirabilis  Pyelonephritis.--Acute  retrograde 
pyelonephritis uniformly was produced in rats by the intravesical injection of 
P. rairabilis. During  the first  2  days hemorrhagic cystitis was  evident.  Or- 
ganisms were isolated only from the bladder, renal and blood cultures being 
negative (Table I, Figs. 1 and 2). On the 3rd day gross infiltrates became evident 
in the kidneys. Concomitant with this, the mean viable bacterial counts in the 
kidneys rose to log10 4.7 organisms per gm wet weight tissue. By 1 week gross 
abscesses increased to a  score of 1.4+  with an associated bacterial count of 
log10 5.9 per gm of kidney. At 6 weeks gross abscesses  had further increased 
(mean 2.8+)  and the viable bacterial count had risen to log10 8.3 organisms 
TABLE  I 
Course  of  Experimental  Pydonephritis  Following the  Intraveslcal  Injection 
of Proteus mirabilis 
Duration of 
Infection 
10 rain. to 
4 hrs. 
1 day 
2 days 
3-4 days 
5-7 days 
2 wks. 
6 wks. 
No. 
rats 
1 
1 
6 
12 
12 
5 
Gross 
abscesses 
(0 to 4+) 
04-0 
04-0 
04-0 
0.87 -4- 3.0 
1.44-1.7 
1.44- 1.2 
2.84- 1.1 
Log of No. 
organisms per 
gm kidney 
0.504-0.96 
0.75 4- 1.1 
04-0 
4.7 4- 3.5 
5.9 4- 4.6 
6.8 4- 3.8 
8.34-1.6 
Log  of  No. 
organisms 
per mlurine 
8.14- 0.71 
;>4.7 
>6.3 
>7.7 4- 0 
Mean 
tlter of 
anti- 
body 
0 
0 
0 
1:80 
1:160 
1:320 
1:1280 
Renal calculi  Blood urea 
(0 to 4+)  nitrogen 
mg per cent 
0 4- 0  --(29.0*) 
0.2 
O. 5  29.0 
0.63 4- 0.53  93.0 4-  89.2 
0.92 4- 0.72  112.,5  4- 132.0 
1.6 4- 0.75  82.4 :t: 100.3 
3.3 4- 0.84  66.2 4- 12.0 
* 29.0 mg per cent is mean of 40 normal rats tested. 
per gm wet weight tissue. As observed in animals with proteus pyelonephritis 
of hematogenous origin, circulating antibodies became detectable at either the 
3rd or 4th day. Renal calculi became apparent during the 1st week. By 6 weeks 
calculi were present in large numbers both in  the bladder and  in  the renal 
pelvis  and were associated with severe hydronephrosis. Blood urea nitrogen 
levels were increased by the 3rd day and ranged from 66 to 112 mg per cent 
during  the  remaining  6  weeks  period  of observation.  Cumulative mortality 
rates varied from 20 to 50 per cent in separate experiments. 
Evaluation  of  Immunization.--The  effectiveness  of  various  methods  of 
active  preimmunization  in  protecting  against  retrograde  pyelonephritis  is 
seen in Table II and Fig. 3. The first method of active immunization evaluated 
was antecedent infection which had been eradicated by antibiotics. At the time 
of  challenge  by  means  of  intravesical  inoculation of  homotypic organisms, 
mean antibody fiters in 2 groups of immunized animals were 1:640 and 1:320. 
Both groups exhibited marked protection against infection with gross abscesses 872  EXPERIMENTAL  RETROGRADE  PYELONEPHRITIS 
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Fro. 2.  Course of retrograde Prongs mirabilis pyelonephritls in rats. Correlation between 
bacteria] multiplication, blood urea nitrogen levels, and development of urinary tract calculi. 
averaging 0.1-t- and 0 as compared to 1.6+  and 2.8+  in controls (P <  0.01). 
Concomitantly,  the  log10 of the  number of organisms  per  gm kidney in  the 
2  immunized groups were  1.2  and  0  as  compared  to  8.1  and  8.3  in  controls 
(P  <  0.01).  As would  be expected,  corresponding to  the lesser degree of in- 
fection in the immunized groups, the degree of renal calculus formation and the 
blood urea nitrogen levels in immunized animals were lower than in controls. 
Animals autopsied at 1 week did not exhibit as marked a  difference in degree 
of stone formation as those autopsied at 6 weeks, inasmuch as even in controls 874  EXPERIMENTAL  RETROGRADE  PYELONEPHRITIS 
relatively few stones were formed at  1 week. Recrudescence of infection was 
not apparent in animals studied 6 weeks after retrograde challenge. 
The second method of active immunization involved the administration of 
heat-killed  organisms  as  antigen.  Prior  to  the  intravesicai  inoculation  of 
organisms  the  mean  titer  of  the  immunized  group  was  1:160.  Again,  pre- 
immunization afforded a marked degree of protection against infection. Gross 
abscesses were 0.06+ in immunized animals as compared to  1.3+  in  controls 
(P  <  0.02).  The log~0 of the  number  of organisms  per  gm kidney was  1.5 
TABLE  II 
Effectiveness of Active  Immunization  in  Experimental  Pyelonephritis  following  Intravesical 
Injection of Proteus 
Type of active 
immunization 
?revious infec- 
tion~ 
Exp. I  (Autop- 
sled at 1-2 wks.) 
Exp. II (Autop- 
sied at 6 wks.) 
Antigen (Autopsied 
at 2 wks.) 
Group 
Immunized 
Controls 
P§ 
Immunized 
Controls 
P 
Immunized 
Controls 
P 
Mean 
titer 
before 
chal- 
lenge 
1:640 
0 
1:320 
0 
1:160 
0 
Gross 
abscesses* 
(0 to 4+) 
11  0.124-0.39 
11  1.6 4- 1.3 
<0.01 
7  04-0 
5  2.84-1.1 
<0.01 
4  0.06 -4- 0.18 
5  1.3 4- 1.4 
<0.02 
Log of No. 
organisms 
~ier gm 
dney* 
1.24-2.3 
8.1 4- 2.8 
<0.01 
04-0 
8.3 4- 1.6 
<0.01 
1.5 4- 1.9 
6.0 4- 3.9 
<0.01 
Renal 
calculi* 
(0 to 4+) 
1.14-1.1 
1.2 4- 0.71 
>0.50 
0.5;' 4-4- 1.5 
3.3 4- 0.84 
<0.01 
1.0 4-4- 0.37 
1.7 4-4- 3.9 
>0.01 
<0.02 
Blood urea 
nitrogen* 
mg per cent 
27.7 -4-  2.8 
84.4 4- 104.7 
>0.05 
d0.10 
26.1  4-  6.5 
66.2 -~ 22.4 
<0.01 
28.3 4-  7.2 
59.6 ~- 38.2 
>0.01 
<0.05 
* Mean -4- sD. 
t  Animals infected 3 weeks previously and then infection eradicated with antibiotics. 
§ P  based on student's method. 
in immunized animals  and  6.0 in control animals  (P  <  0.01).  Renal  calculi 
and blood urea nitrogen levels were reduced in the immunized groups. 
Passive prechallenge immunization (Table III, Fig. 3) also protected animals 
against  retrograde pyelonephritis.  Rats  given  1  ml  of hyperimmune rabbit 
antiproteus serum 4 hours before challenge had a mean antibody titer of 1:80 
at the time of challenge. At 1 week gross abscesses in this group were 0.01+ 
as compared to 0.7+ in a control group of animals (P =  0.05). Correspondingly, 
the log10 of the number of organisms in the immunized group was  1.2 as com- 
pared to 3.7 in the control group (P =  0.05). 
DISCUSSION 
These observations demonstrated that preimmunization, whether the result 
of pyelonephritis which  had been eradicated,  the result of administration  of BETTY  W. HUNTER,  LONA  L. AKINS,  AND  JAY P. SANFORD  875 
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heat-killed  antigen,  or  the  result  of  the  passive  administration  of  specific 
rabbit antiserum, protected rats against retrograde pyelonephritis when chal- 
lenged  with  homotypic  organisms.  The  evidence  from  the  present  studies 
strongly suggests that accelerated vascular clearance of organisms could not 
be  the  sole  mechanism of protection.  Thus,  during  the  6  weeks  interval of 
experimental  observation,  preimmunization  must  either  have  prevented  or 
retarded the multiplication of P. mirabilis within the renal parenchyma. 
The  concept that accelerated vascular clearance is  not the mechanism of 
protection is substantiated by the findings of Braude and Siemienski, who re- 
ported that clearance of E. coli from the blood during the first 5 minutes was 
not increased by immunization (6).  Furthermore, in agreement with our ob- 
TABLE  III 
Effectiveness of Passive Immunization* in Experimental  Pyelonephritis  Following Intravesical 
Injection of Proteus  (Animals Autopsied at 1 Week) 
Group 
Immunized... 
Controls ...... 
P§ ........... 
Mean 
titer 
before  No. 
chal-  rats 
lenge 
1:80  7 
0  7 
Gross abscesses~: 
(0 to 4+) 
0.01 -4- 0.03 
0.72 -4- 1.34 
0.05 
* Given 1 ml of hypenmmune  rabbit anti 
~/Mean -4-  sD. 
§ P based on Student's method. 
Log of No. 
organisms per 
gm kidney~ 
1.2.4.2.7 
3.7-4-3.7 
0.05 
Renal calculi:~ 
0.33  -4- 0.45 
0.24 -4- 0.17 
>0,50 
Blood urea 
nitrogen~; 
ntg per gent 
39.7.4- 18.7 
51.7 -4- 33.3 
>o.Io 
<0.50 
9roteus serum 4  hours before challenge. 
servations, Arana, Kozij, and Jackson reported that preimmunization against 
E.  coli  0-22  had an early protective effect against retrograde pyelonephritis 
in rats. However, they reported that preimmunized animals developed chronic 
pyelonephritis  several  weeks  after  the  initial  retrograde  challenge  (7).  An- 
dersen and Jackson previously had demonstrated that pyelitis represented the 
initial phase in  the pathogenesis of retrograde pyelonephritis in rats  (8,  9). 
Pyelonephritis  was  the  result  of  subsequent  cortical  extension  of  chronic 
pyelitis. Their data would suggest that Preimmunization may have suppressed 
but did not prevent the establishment of low-grade pyelitis which later pro- 
gressed. In contrast, during 6 weeks observation we did not observe the delayed 
development of pyelonephritis after an initial interval of protection. An ex- 
planation for this discrepany is not readily apparent although different bac- 
terial  species  were  employed. An  alternative possibility could be  suggested 
from the  experiments of Beeson and  Rowley, who demonstrated that  renal 
homogenates exert an anticomplementary action involving inactivation of the BETTY  W.  HUNTER,  LONA  L.  AKINS,  AND JAY  P.  SAN'gORD  877 
fourth component of complement, probably through the formation of ammonia 
(10). An increase  in acid-ash  residue  in the diet would increase ghitaxninase 
activity of renal  tubular  cells and  as  a  consequence  of the  countercurrent 
mechanisms would result in a marked increase in tissue ammonia content in 
the renal papillae  (11). Variation in tissue ammonia levels with concomitant 
variation in complement activity could significantly influence the effectiveness 
of preimmunization. 
From review of earlier studies, three patterns of hematogenous pyelonephritis 
emerged  to suggest  that immunity was a  significant  determinant (1). First, 
the course of pyelonephritis  due to strains of Escherichia coli was acute, self- 
limited, and associated  with the development of circulating  agglutinins.  Fol- 
lowing healing, this pattern of infection was associated with acquired resistance 
to reinfection with the same bacterial strain. Second, the course of pyelonephritis 
due to a strain of Kle.bsiella pneumonia~ type C was chronic. This infection was 
not associated  with the production of circulating  agglutinins  against encap- 
sulated strains.  Acquired  resistance  to  reinfection  by the  homotypic strain 
could not be demonstrated following eradication of infection but was produced 
by the passive  transfer of concentrated antiserum.  Third, pyelonephritis  due 
to Proteus ~nirabilis was associated with circulating  agglutinins and resistance 
to reinfection  with the same organism following eradication  of infection. Yet 
the course of infection was chronic when uninterrupted by specific antibacterial 
therapy (1, 5). The chronicity appeared  to be the consequence of obstructive 
uropathy resulting from calculi which developed during the course of the in- 
fection. 
The experimental  animal data of Jackson and coworkers indicate that im- 
munization after establishment of infection did not eradicate bacteria from 
the pelvis or medulla although extension into the cortex was decreased (9, 12). 
We would concur in their conclusions that: "Little support is gained therefore 
for any benefit to be derived from vaccine administration in the treatment of 
established urinary infection with a similar strain." However, there are clinical 
data  which  suggest  that  recurrent  urinary  tract  infections  often represent 
reinfection with serologically distinct bacteria rather than recrudescence of an 
initial infecting organism (13, 14). Under such circumstances preimmunization 
by prior infection may be an important determinant to the course of reinfection 
or  even  parenchymal progression  and  renal  destruction in  non-obstructive 
pyelonephritis. 
Current studies  correlating  the antibody response of patients with urinary 
tract infections to the infecting organisms are preliminary and do not enable 
unequivocal evaluation of the hypothesis that immunity  represents a significant 
determinant in pyelonephritis  (15, 16). Furthermore,  clinical interpretation 
of the role of immunity as a determinant in pyelonephritis will require apprecia- 
tion of the experimental  observation that "obstructive uropathy" may either 
modify or nullify the protective action of antibody (1). 878  EXPERIMENTAL  RETROGRADE  PYELON'EPHRITIS 
The earlier demonstration that in experimental pyelonephritis preimmuniza- 
tion had a  significant role in resistance  to reinfection by the hematogenous 
route of challenge strengthened by the present observation that preimmuniza- 
tion  protected  rats  against  retrograde  pyelonephritis  when  challenged  by 
homotypic organisms emphasizes the need to attempt further to elucidate the 
role of immunity in clinical pyelonephritis. 
SUMMARy 
Retrograde pyelonephritis was produced in rats by the intravesical injection 
of Proteus mirabilis. When animals were preimmunized against Proteus mirabilis 
by (a) prior infection, (b) administration of antigen, or (c) passively transferred 
antiserum, they were resistant to infection by proteus when challenged by the 
retrograde route. 
The protective effect of specific preimmunization in retrograde pyelonephritis 
indicates that a major site of action is retardation of bacterial growth within 
the parenchyma of the kidney. 
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